ClinicalTrials.gov
public full text
Public Domain
Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune Diseases
This study evaluates the immunomodulatory effects of subcutaneous progesterone in patients undergoing IVF by determination of anti-nuclear antibodies (ANA),extractable nuclear antigen antibodies (ENA),anti- neutrophil cytoplasmic antibodies(ANCA),anti-DNA antibodies, anti-cardiolipin antibodies (ACA),Lupus anticoagulant antibodies (LAC) and C3 and C4 fractions of complement on the day of beta hCG dosage and during the eigth week of gestation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women#471486
- Increasing Influenza and Tdap Vaccination of Pregnant Women#633747
- Efficacy and Safety of Canakinumab in Schnitzler Syndrome#810150
- The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis#1044630
- Text Message Reminders for Influenza Vaccine in Pregnancy#858474
Record · ID 1444916
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive